Scientist profiles M-R
Sunnybrook Health Sciences Centre
2075 Bayview Ave.,
Executive Assistant: Meredith Malloy
Phone: 416-480-6100, ext. 2895
- BA, 1983, philosophy and comparative literature, Johns Hopkins University, U.S.
- MD, 1987, Jefferson Medical College, U.S.
- M.Sc., 1996, epidemiology, University of Washington, U.S.
Appointments and Affiliations:
- Senior scientist, Evaluative Clinical Sciences, Trauma, Emergency & Critical Care Research Program, Sunnybrook Research Institute
- Chief, Trauma, Emergency & Critical Care Program, Sunnybrook Health Sciences Centre
- Associate staff, critical care medicine, Sunnybrook
- Professor of medicine, interdepartmental division of critical care, University of Toronto
- Pulmonary medicine
- Mechanical ventilation
- Clinical epidemiology
- Critical care medicine
- Health services research
- Knowledge transfer
Gordon Rubenfeld is the inaugural chief of the Trauma, Emergency & Critical Care Program at Sunnybrook Health Sciences Centre and professor of medicine at the University of Toronto. Dr. Rubenfeld received his undergraduate degree in philosophy and comparative literature at Johns Hopkins University; his medical degree from Jefferson Medical College; his internal medicine training at Duke University; and pulmonary and critical care training at the University of Washington. He received additional research training in clinical epidemiology as a Robert Wood Johnson Clinical Scholar at the University of California, San Francisco. He served on numerous professional society committees for the American Thoracic Society (ATS), including bioethics, critical care long-range planning and health policy, and as chair of the Critical Care Assembly. He directed the advanced clinical research section of the methods in epidemiologic, clinical and operations research course administered by the ATS. He served on the editorial boards of the American Journal of Respiratory and Critical Care Medicine, Respiratory Care, the Journal of Critical Care, Critical Care, and The Lancet-Respiratory Medicine.
Dr. Rubenfeld's research focuses on the clinical epidemiology and outcomes of critical illness syndromes, the transfer of evidence into clinical practice, and end-of-life care issues in the intensive care unit. His research is funded primarily by the National Institutes of Health. He served on numerous advisory panels and consensus groups in critical care, including the American European Consensus Conference on Acute Lung Injury, the working group that developed the Berlin ARDS (acute respiratory distress syndrome) definition, and the Surviving Sepsis guideline committee. He has served on study sections for the National Institutes of Health and the Canadian Institutes of Health Research.
Ongoing projects include a cluster-randomized trial of interventions to increase use of lung protective ventilation in patients with acute lung injury, and a randomized trial to improve long-term outcomes in survivors of prolonged mechanical ventilation.